InterCure Ltd.
INCR
$0.15
Change (1 day)
$3.72
Year High
$1.17
Year Low
Categories
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
P/E ratio for InterCure Ltd. (INCR)
P/E ratio as of 2023: -3.60
According to InterCure Ltd.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.60. At the end of 2022 the company had a P/E ratio of 12.62.
P/E ratio history for InterCure Ltd. from 2010 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -3.60 |
| 2022 | 12.62 |
| 2021 | 133.25 |
| 2020 | -11.52 |
| 2019 | -128.89 |
| 2018 | -36.23 |
| 2017 | -5.20 |
| 2016 | 121.23 |
| 2015 | -7.34 |
| 2014 | -1.65 |
| 2013 | -1.03 |
| 2012 | 0.17 |
| 2011 | -98.07 |
| 2010 | -639.06 |